- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
19 result(s) found for: Neurophysiology.
Displaying page 1 of 1.
EudraCT Number: 2011-004636-66 | Sponsor Protocol Number: KP-2011-0077 | Start Date*: 2011-12-05 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: Single-blinded randomized trial of Botulinumtoxin A (Vistabel®) and its objective paralytic effect in the facial muscles of healthy women: development of new neurophysiological measurements. | ||
Medical condition: The treatment of glabellar lines in healthy women by muscle paralysis from injection of botulinum toxin | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000986-40 | Sponsor Protocol Number: EVT 101/1002 | Start Date*: 2007-08-07 |
Sponsor Name:Evotec NeurosciencesGmbH | ||
Full Title: A double blind, placebo controlled study to investigate the role of NMDA receptor NR2B subunit selective antagonism on cognitive functions and neurophysiology in healthy subjects as measured with MRI | ||
Medical condition: Investigation of cognitive function and neurophysiology. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000606-11 | Sponsor Protocol Number: 5502071979 | Start Date*: Information not available in EudraCT |
Sponsor Name:Region Ostergotland | ||
Full Title: Melatonin compared to sleep deprivation for sleep EEG recordings in children: impact on epileptiform discharges and sleep, contributing factors on the results and the influence on children's and pa... | ||
Medical condition: suspected epilepsy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003514-39 | Sponsor Protocol Number: GNCbumet | Start Date*: Information not available in EudraCT |
Sponsor Name:Gillberg Neuropsychiatry Centre | ||
Full Title: Testing E/I imbalance in autism with Bumetanide – a parallel group randomized waitlist-control trial in adolescents and adults | ||
Medical condition: Autism Spectrum Disorder | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000479-40 | Sponsor Protocol Number: D1449L00030 | Start Date*: 2007-09-12 |
Sponsor Name:Department of Psychiatry, RWTH Aachen | ||
Full Title: Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology | ||
Medical condition: Bipolar disorder is a common psychiatric disorder which is characterised by manic and depressive states. The mood stabilizing effect of novel antipsychotics seems to be modulation of neuronal plast... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002506-37 | Sponsor Protocol Number: SANNI-project:03 | Start Date*: 2020-01-08 |
Sponsor Name:Region Skane | ||
Full Title: Dexmedetomidine for analgosedation to newborn infants during neonatal intensive care – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study.Cohort 3 in The SANNI Pr... | ||
Medical condition: Sick newborn infants in need of intensive care. | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005091-26 | Sponsor Protocol Number: SANNI-project:02 | Start Date*: 2018-02-13 |
Sponsor Name:Skåne University Hospital | ||
Full Title: Clonidine for analgesia to preterm infants during neonatal intensive care – a prospective pharmacokinetic/pharmacodynamic/pharmacogenetic observational study. Cohort 2 in The SANNI project. | ||
Medical condition: Sick preterm infants undergoing neonatal intensive care. | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002470-20 | Sponsor Protocol Number: SANNI-project:01 | Start Date*: 2017-04-11 |
Sponsor Name:Skåne University Hospital | ||
Full Title: Fentanyl and Clonidine for analgesia during hypothermia in term asphyxiated infants – a prospective pharmacokinetic/ pharmacodynamic/ pharmacogenetic observational study. Cohort 1 in The SANNI proj... | ||
Medical condition: Infants with induced hypothermic treatment after perinatal asphyxia | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002383-16 | Sponsor Protocol Number: CME-LEM4 | Start Date*: 2016-01-19 |
Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | ||
Full Title: Evaluate the efficacy of the cell therapy with NC1 medication in patients with post-traumatic syringomyelia | ||
Medical condition: Traumatic spinal cord injury, chronically established, associated with syringomyelia and neurological deficit considered irreversible. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005613-24 | Sponsor Protocol Number: CME-LEM3 | Start Date*: 2015-06-19 |
Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | ||
Full Title: Intrathecal administration (pattern 100/3) of expanded autologous adult bone marrow mesenchymal troncal cells in established chronic spinal cord injuries | ||
Medical condition: Traumatic or ischemic spinal cord injury, chronically established and considered irreversible | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-000975-10 | Sponsor Protocol Number: CME-LEM5 | Start Date*: 2017-09-25 |
Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro Majadahonda | ||
Full Title: Intrathecal administration of bone marrow adult autologous stem mesenchymal cells expanded in chronically established low injuries of the spinal cord | ||
Medical condition: Traumatic or ischemic spinal cord injury, chronically established and considered irreversible | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-001824-23 | Sponsor Protocol Number: CME-LEC1 | Start Date*: 2017-11-29 |
Sponsor Name:Fundación de Investigación Biomédica del Hospital Universitario Puerta de Hierro-Majadahonda (FIBM-HUPHM) | ||
Full Title: Intrathecal administration of autologous adult bone marrow mesenchymal stem cells expanded in the diffuse axonal injury. | ||
Medical condition: Traumatic cerebral injury, chronically established attributed to diffuse axonal injury. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-000141-52 | Sponsor Protocol Number: Landscaping_2017 | Start Date*: 2017-04-03 | |||||||||||
Sponsor Name:Asbjørn Mohr Drewes | |||||||||||||
Full Title: The effect of tapentadol on the human pain system: A study based on advanced neurophysiology and imaging techniques to illustrate the mechanism of tapentadol and oxycodone in the central, autonomic... | |||||||||||||
Medical condition: Healthy volunteers - pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003386-18 | Sponsor Protocol Number: CandMigIII | Start Date*: 2019-12-18 | |||||||||||
Sponsor Name:Department of Neurology and Clinical Neurophysiology, St Olavs Hospital, Trondheim University hospital | |||||||||||||
Full Title: CandMig III study Candesartan for migraine prevention: A multicentre, binational, triple blind, placebo controlled, parallel group study of two doses of candesartan (8 and 16 mg) | |||||||||||||
Medical condition: Episodic migraine with and without aura | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) EE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005377-23 | Sponsor Protocol Number: SCI-GHD-201 | Start Date*: 2012-07-18 | ||||||||||||||||
Sponsor Name:Guillem Cuatrecasas Cambra | ||||||||||||||||||
Full Title: A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN® in combination with intensive r... | ||||||||||||||||||
Medical condition: Spinal Cord Injury and Growth Hormone Deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005069-15 | Sponsor Protocol Number: LIGHTHOUSEII | Start Date*: 2021-06-23 | |||||||||||
Sponsor Name:Stichting TRICALS Foundation | |||||||||||||
Full Title: RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 TRIAL OF TRIUMEQ IN AMYOTROPHIC LATERAL SCLEROSIS | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis (ALS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) IE (Ongoing) ES (Ongoing) SI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002258-30 | Sponsor Protocol Number: M/SATIVX/01 | Start Date*: 2011-10-04 | |||||||||||
Sponsor Name:ALMIRALL PRODESFARMA | |||||||||||||
Full Title: NEUROPHYSIOLOGIC STUDY AIMED AT EVALUATING ON EFFECT OF SATIVEX® ON SPASTICITY IN PROGRESSIVE MULTIPLE SCLEROSIS | |||||||||||||
Medical condition: Subject of both male and female gender affected by Secondary-Progressive (SP) or Primary-Progressive (PP) MS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-000419-98 | Sponsor Protocol Number: B4Z-US-LYEI | Start Date*: 2021-12-13 | ||||||||||||||||
Sponsor Name:Eli Lilly and Company | ||||||||||||||||||
Full Title: Neurophysiology of Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Dyslexia: Functional Magnetic Resonance Imaging (fMRI) Measures of Brain Activation During Attention and Reading Tas... | ||||||||||||||||||
Medical condition: Attention Deficit Hyperactivity Disorder, Dyslexia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005557-73 | Sponsor Protocol Number: I10E-1302 | Start Date*: 2014-10-21 | |||||||||||
Sponsor Name:LFB BIOTECHNOLOGIES | |||||||||||||
Full Title: An international, multicentre, efficacy and safety study of I10E in initial and maintenance treatment of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy | |||||||||||||
Medical condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) IT (Completed) FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.